Interestingly, S100A6 upregulation in astrocytes has been observed in patients suffering from amyotrophic lateral sclerosis (ALS) [28], and around amyloid plaque deposits in AD patients and transgenic AD model animals [29]. Here, S100A6 is linked to Alzheimer disease.